Variable proteolytic cleavage of gag precursor expressed after infection of several cell lines with an HIV-2 gag-pol recombinant vaccinia virus.
Mars
M
M
Institut Jacques Monad du C.N.R.S., Paris, France.
Beaud
G
G
Zagury
J F
JF
Fossati
I
I
D002460:Cell Line; D015685:Fusion Proteins, gag-pol / Q000235:genetics*; D015683:Gene Products, gag / Q000235:genetics* / Q000378:metabolism*; D015498:HIV-2 / Q000235:genetics*; D011498:Protein Precursors / Q000378:metabolism*; D011995:Recombination, Genetic; D014616:Vaccinia virus / Q000235:genetics*
D015685:Fusion Proteins, gag-pol; D015683:Gene Products, gag; D011498:Protein Precursors; C059767:p55 gag precursor protein, Human immunodeficiency virus 1